We are researchers and investigators at sarcoma centers working together with pharmaceutical and biotech companies to achieve breakthroughs in sarcoma – to help improve patient outcomes, and ultimately find a cure.

The SARC organization is set up as a directorship, and the organization’s overall strategy and policy is guided by members of the board. Our scientific platform is established by leaders who are recognized experts in sarcoma research. Within this organizational structure we are positioned to bring together the range of expertise needed to move the science of sarcoma forward to develop new and better treatments for patients with sarcoma.

Operations Office
Board of Directors
Scientific Steering Committee
Discovery Translation Committee
SARC Research Advocacy Council

Board of Directors

Under the guidance of the Board of Directors, SARC’s policies and strategies are established and refined on a regular basis. Our board consists of individuals from a range of backgrounds and areas of expertise to ensure that different viewpoints are represented as strategies are crafted to support SARC’s mission. The board meets quarterly, and as needed, to conduct the important business of SARC.

Ernest “Chappie” Conrad II

Ernest “Chappie” Conrad II, MD

Chair of the Board

McGovern Medical School, The University of Texas Health Science Center at Houston
Read Bio

Jonathan Fletcher, MD

Board Member, Chief Scientific Officer

Harvard Medical School, Brigham and Women’s Hospital, Dana-Farber Cancer Institute
Read Bio
Eva Gallagher

Eva Gallagher, PhD

Board Member, Corporate Secretary

Agios Pharmaceuticals; Georgetown University
Read Bio

Ann Graham

Board Member

MIB Agents
Read Bio

Scott Okuno, MD

Chief Medical Officer

Mayo Clinic
Read Bio

Marlene Portnoy

Board Member

Co-Founder/Former Executive Director of the Desmoid Tumor Research Foundation
Read Bio

Timothy Timmerman

Board Member, Corporate Treasurer

Tax Department, Cardinal Health
Read Bio
Andrew Wagner

Andrew J. Wagner, MD, PHD

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Read Bio
Steven W. Young

Steven Young

President & CEO

Read Bio

Scientific Steering Committee

Karla Ballman

Karla Ballman, PhD

Weill Cornell Medical College
Read Bio

Sandra D’Angelo, MD

Memorial Sloan Kettering Cancer Center
Read Bio

Lara Davis, MD

Oregon Health & Science University
Read Bio

Jonathan Fletcher, MD

Chief Scientific Officer

Harvard Medical School, Brigham and Women’s Hospital, Dana-Farber Cancer Institute
Read Bio

Scott Okuno, MD

Chief Medical Officer

Mayo Clinic
Read Bio
Shreyaskumar Patel

Shreyaskumar Patel, MD

University of Texas MD Anderson Cancer Center
Read Bio
Andrew Wagner

Andrew J. Wagner, MD, PHD

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Read Bio
Steven W. Young

Steven Young

President & CEO

Read Bio

Discovery Translation Committee

Discovery efforts focus on the pathological mechanisms underpinning common illnesses throughout the body, including cancer. Translational research applies discoveries generated in the laboratory to studies in humans (bench to bedside), or that speeds the adoption of best practices into community settings (bedside to practice). SARC’s Discovery/Translation Committee’s mandate is to expand SARC’s commitment to discovery and translational sciences. One of the Committee’s most immediate goals is to integrate more science in each SARC clinical trial, explaining why new therapies help some people and not others – this will enable SARC refine the therapeutic approaches, helping more people and reducing needless treatment toxicity.

Ping Chi

Ping Chi, MD, PHD

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Read Bio
Liz Demicco

Liz Demicco, MD, PHD

Department of Laboratory Medicine & Pathobiology, University of Toronto
Read Bio

Jonathan Fletcher, MD

Chief Scientific Officer

Harvard Medical School, Brigham and Women’s Hospital, Dana-Farber Cancer Institute
Read Bio
Kevin Jones

Kevin Jones, MD, PhD

Sarcoma Disease Center, Sarcoma Department of Orthopaedics, Hunstman Cancer Center
Read Bio
Troy McEachron

Troy McEachron, PhD

Mayo Clinic; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health
Read Bio
Sethe Pollack

Seth Pollack, MD

Lurie Cancer Center, Northwestern University
Read Bio
Christine Pratalis

Christine Pratilas, MD

Pediatrics & Cellular and Molecular Medicine, John Hopkins University School of Medicine
Read Bio
Keila Torres

Keila Torres, MD, PhD, MBA, FACS

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
Read Bio
Matt van de Rijn

Matt van de Rijn, MD, PhD

Pathology, Stanford University School of Medicine, Ludwig Cancer Center
Read Bio
Andrew Wagner

Andrew J. Wagner, MD, PHD

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Read Bio
Brigitte Widemann

Brigitte Widemann, MD

Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health
Read Bio

SARC Operations Offfice

The team of individuals at SARC’s operations office provides the range of expertise needed to support the organization’s scientific leadership and sustain the infrastructure necessary to facilitate the conduct of research.

Meghan Blalock

Research Project Manager

Read Bio

Brandi Hall Clarke, MS

Contracts and Grants Administrator

Read Bio

Caralynn Hampson

Sarcoma Survivor, SARC Intern

Read Bio
Claudia Hill

Claudia Hill

Director of Business Operations

Read Bio
Erin Kozlowski

Erin Kozlowski, MSA

Senior Research Project Manager

Read Bio
Lindsey Overman Portrait

Lindsey Overman, MS, CCRP

Research Project Manager

Read Bio

Angel Funk Parry, MPA

Development Associate

Read Bio
Lori Smith

Lori Smith

Finance Manager

Read Bio
Steven W. Young

Steven Young

President & CEO

Read Bio

SARC Research Advocacy Council

The SARC Research Advocacy Council (RAC) was created using the model established by the National Cancer Institute (NCI) for engagement of patient advocates to become “research advocates” across four key functions: advise, design, review, and disseminate. A number of individual patient advocates have agreed to serve as research advocates on the SARC Research Advocacy Council. The council convenes regularly to explore opportunities to interface with researchers. More about RAC

Annie Achee

President, National Leiomyosarcoma Foundation
Read Bio
Mitch Achee

Mitch Achee, MD

Retired Radiologist; Leiomyosarcoma Survivor, National Leiomyosarcoma Foundation
Read Bio
Felice Adler

Felice Adler, MD

Clinical Professor of Pediatrics & Advocate, University of California Irvine; Advocate, Ewing's Sarcoma Cure Coalition, Rutledge Foundation, St. Baldrick's Foundation
Read Bio

Robin Allen, PHD, MSW

LMSDR Board of Directors Member and LMS Survivor

RAC Member
Read Bio

Rev. Dr. Stacey Simpson Duke

Leiomyosarcoma Survivor
Read Bio
Peter Fantozzi

Peter Fantozzi

Patient Advocate & Representative, Northwest Sarcoma Foundation
Read Bio

Caralynn Hampson

Sarcoma Survivor, SARC Intern

Read Bio

Allison Sole

Director of Biomedical Programs, Slifka Foundation
Read Bio
Lennie Woods

Lennie Woods

Co-Founder & Executive Director, Clear Cell Sarcoma Foundation
Read Bio
Lisa De Young

Lisa De Young

Patient Liaison & Administrator, Sarcoma Coalition; International EHE Support Group
Read Bio
Back to top